Intermittent fasting for people at high risk of pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests whether following an intermittent fasting schedule (eating only during certain hours) can help people at high risk for pancreatic cancer. The trial uses an app to track eating patterns and fasting times, aiming to see if this approach may reduce cancer risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be considered at high risk for pancreatic cancer (for example, due to a gene change, strong family history, pancreatic cysts, new diabetes, or ongoing pancreatitis).
- You must be willing to change when you eat (follow an intermittent fasting schedule).
- You must be willing to track your fasting times using a mobile app.
- You must not be underweight (BMI less than 18.5), have a history of low blood sugar, be pregnant or breastfeeding, or have serious cognitive impairment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether intermittent fasting can improve how your body releases and uses insulin if you have prediabetes or early type 2 diabetes. It may help your blood sugar control without using insulin.
This trial tests an AI-powered app that helps with nutrition after pancreatic cancer surgery. It aims to improve your recovery by giving personalized dietary guidance.
This study tests whether intermittent fasting (alternating periods of eating and fasting) can help with weight loss and health in adults with obesity. It aims to see if this approach is safe and effective.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
This trial tests a new study drug called FID-022 for people with pancreatic cancer. It is a first-in-human study, meaning it is the first time this drug is being tested in people, and researchers want to see if it is safe and how it works.
Hear when a new Intermittent Fasting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.